BridgeBio Pharma’s approval of Beyonttra comes three months after the drug landed FDA approval for cardiomyopathy caused by transthyretin amyloidosis. Our recap of recent regulatory news also spans approvals in cancer, immunology, vaccines, and more.

The distinction between value-based care and value-based payment isn’t merely semantic — it represents a crucial fork in the road for healthcare delivery. As AI and other technologies become more prevalent in healthcare, we must ensure they’re deployed in service of improving patient care rather than merely optimizing revenue.

Memorial Sloan Kettering Cancer Center partnered with AWS to accelerate its research with AI. The collaboration seeks to speed up drug discovery and increase activity within the health system’s startup accelerator.

Virtual care is no longer just a convenience, it is a necessity. The question is no longer whether virtual-first care is viable but how quickly we can make it the preferred model for modern healthcare.

Merck’s implementation of artificial intelligence in drug research includes analyzing years of existing Merck clinical data to help identify which drugs and drug combinations to pursue. But Merck executive Matt Studney said AI is tool to help, not replace humans.

Tufts University, Kaiser Permanente and several other healthcare organizations recently launched the Food is Medicine National Network of Excellence. The network aims to develop, assess and share the best practices in the food-is-medicine space.

AI-generated simulations can standardize diversity in exposure by creating virtual patients from varied backgrounds, each with unique risk factors and life experiences.